Evaluate the Effort Test as a Therapeutic Monitoring Tool in Acute Rhabdomyolyses

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

October 25, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Rhabdomyolysis Linked to a Hereditary Disease of Metabolism
Interventions
OTHER

Effort test

"Cardiac function:~Echocardiography: left ventricular ejection fraction and global longitudinal strain will be measured.~Cardiopulmonary exercise test (CPET): left ventricular stroke volume was assessed noninvasively using a thoracic bioelectrical impedance device : maximal stroke volume at the peak of effort will be considered.~Peripheral muscle function:~* CPET: Oxygen uptake (VO2) (and carbon dioxide) output are measured. The slope of the relationship (dQ/dVO2) will be calculated between cardiac output (Q) and VO2 using measurements of Q (using measure of the stroke volume by thoracic bioelectrical impedance device) and VO2 at rest as well as during submaximal and maximal exercise~* Muscle oxygenation is measured using a near-infrared spectroscopy device.~* VO2 et Q will be measured : dQ/dVO2 is high in case of oxydation defect; If Q is low because of a concommittant cardiac impairement, the DAV = VO2/Q, and DO = (Q x DAV) / (200 - DAV) will be calculated."

OTHER

Functional tests on fibroblasts

Functional tests performed on fibroblasts in primary culture, using as tracers of stable isotope-labeled substrates. The metabolites of interest are assayed in mass spectrometry.

Trial Locations (1)

75015

Hôpital Necker-Enfants Malades, Paris

All Listed Sponsors
collaborator

URC-CIC Paris Descartes Necker Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03802279 - Evaluate the Effort Test as a Therapeutic Monitoring Tool in Acute Rhabdomyolyses | Biotech Hunter | Biotech Hunter